GM
Gina Mazzariello
Chief Legal Officer

Gina Mazzariello insider trades: Amylyx Pharmaceuticals (AMLX) stock sales

Chief Legal Officer, Amylyx Pharmaceuticals Last trade Sep 10, 2026 25 Form 4 filings
$508K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gina reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 10, 2026AMLX↓ Sell$310K
Mar 2, 2026AMLX↓ Sell$99K
Feb 23, 2026AMLX↓ Sell$48K
Feb 2, 2026AMLX↓ Sell$51K
Sep 30, 2025AMLX↓ Sell$129K
Aug 13, 2025AMLX↓ Sell$246K
Mar 31, 2025AMLX↓ Sell$32K
Mar 3, 2025AMLX↓ Sell$5K
Feb 24, 2025AMLX↓ Sell$13K
Feb 3, 2025AMLX↓ Sell$13K
Sep 30, 2024AMLX↓ Sell$28K
May 15, 2024AMLX↓ Sell$20K
Mar 5, 2024AMLX↓ Sell$29K
Feb 23, 2024AMLX↓ Sell$53K
Aug 15, 2023AMLX↓ Sell$129K
Feb 24, 2023AMLX↓ Sell$124K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AMLX insiders

Open-market trades in the last 12 months

About Gina Mazzariello's insider trades

Gina Mazzariello is Chief Legal Officer at Amylyx Pharmaceuticals (AMLX). Since Feb 24, 2023, Gina has reported no open-market purchases and 16 sales worth $1.3M on SEC Form 4. In the last 12 months: 4 sales ($508K).

Their filings also include grants and awards (7 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMLX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.